125 related articles for article (PubMed ID: 29788341)
1. Lessons Learned in Clinical Trial Communication During an Ebola Outbreak: The Implementation of STRIVE.
Callis A; Carter VM; Ramakrishnan A; Albert AP; Conteh L; Barrie AA; Fahnbulleh L; Koroma MM; Saidu S; Williams O; Samai M
J Infect Dis; 2018 May; 217(suppl_1):S40-S47. PubMed ID: 29788341
[TBL] [Abstract][Full Text] [Related]
2. Monitoring Serious Adverse Events in the Sierra Leone Trial to Introduce a Vaccine Against Ebola.
Jarrett OD; Seward JF; Fombah AE; Lindblad R; Jalloh MI; El-Khorazaty J; Dawson P; Burton D; Zucker J; Carr W; Bah MM; Deen GF; George PM; James F; Lisk DR; Pratt D; Russell JBW; Sandy JD; Turay P; Hamel MJ; Schrag SJ; Walker RE; Samai M; Goldstein ST
J Infect Dis; 2018 May; 217(suppl_1):S24-S32. PubMed ID: 29788346
[TBL] [Abstract][Full Text] [Related]
3. The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV∆G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak.
Samai M; Seward JF; Goldstein ST; Mahon BE; Lisk DR; Widdowson MA; Jalloh MI; Schrag SJ; Idriss A; Carter RJ; Dawson P; Kargbo SAS; Leigh B; Bawoh M; Legardy-Williams J; Deen G; Carr W; Callis A; Lindblad R; Russell JBW; Petrie CR; Fombah AE; Kargbo B; McDonald W; Jarrett OD; Walker RE; Gargiullo P; Bash-Taqi D; Gibson L; Fofanah AB; Schuchat A;
J Infect Dis; 2018 May; 217(suppl_1):S6-S15. PubMed ID: 29788345
[TBL] [Abstract][Full Text] [Related]
4. Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola.
Conteh MA; Goldstein ST; Wurie HR; Gidudu J; Lisk DR; Carter RJ; Seward JF; Hampton LM; Wang D; Andersen LE; Arvay M; Schrag SJ; Dawson P; Fombah AE; Petrie CR; Feikin DR; Russell JBW; Lindblad R; Kargbo SAS; Samai M; Mahon BE
J Infect Dis; 2018 May; 217(suppl_1):S33-S39. PubMed ID: 29788347
[TBL] [Abstract][Full Text] [Related]
5. Participant Retention in a Randomized Clinical Trial in an Outbreak Setting: Lessons From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).
Carter RJ; Senesi RGB; Dawson P; Gassama I; Kargbo SAS; Petrie CR; Rogers MH; Samai M; Luman ET
J Infect Dis; 2018 May; 217(suppl_1):S65-S74. PubMed ID: 29788348
[TBL] [Abstract][Full Text] [Related]
6. Implementing a Multisite Clinical Trial in the Midst of an Ebola Outbreak: Lessons Learned From the Sierra Leone Trial to Introduce a Vaccine Against Ebola.
Carter RJ; Idriss A; Widdowson MA; Samai M; Schrag SJ; Legardy-Williams JK; Estivariz CF; Callis A; Carr W; Webber W; Fischer ME; Hadler S; Sahr F; Thompson M; Greby SM; Edem-Hotah J; Momoh RM; McDonald W; Gee JM; Kallon AF; Spencer-Walters D; Bresee JS; Cohn A; Hersey S; Gibson L; Schuchat A; Seward JF
J Infect Dis; 2018 May; 217(suppl_1):S16-S23. PubMed ID: 29788343
[TBL] [Abstract][Full Text] [Related]
7. Comment: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).
Schuchat A; Seward JF; Goldstein ST; Mahon BE
J Infect Dis; 2018 May; 217(suppl_1):S1-S5. PubMed ID: 29788344
[No Abstract] [Full Text] [Related]
8. Health Conditions in an Adult Population in Sierra Leone: Data Reported From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).
Fombah AE; Goldstein ST; Jarrett OD; Jalloh MI; El-Khorazaty J; Lisk DR; Legardy-Williams J; Pratt DA; George PM; Russell JBW; Schrag SJ; Dawson P; Deen GF; Carr W; Lindblad R; James F; Bah MM; Yillia JF; Sandy JD; Turay PE; Conteh MA; Slutsker L; Mahon BE; Samai M; Seward JF
J Infect Dis; 2018 May; 217(suppl_1):S75-S80. PubMed ID: 29788342
[TBL] [Abstract][Full Text] [Related]
9. Operationalizing International Regulatory Standards in a Limited-Resource Setting During an Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE) Experience.
Kabineh AK; Carr W; Motevalli M; Legardy-Williams J; Vincent W; Mahon BE; Samai M
J Infect Dis; 2018 May; 217(suppl_1):S56-S59. PubMed ID: 29788349
[TBL] [Abstract][Full Text] [Related]
10. Rapid Establishment of a Cold Chain Capacity of -60°C or Colder for the STRIVE Ebola Vaccine Trial During the Ebola Outbreak in Sierra Leone.
Jusu MO; Glauser G; Seward JF; Bawoh M; Tempel J; Friend M; Littlefield D; Lahai M; Jalloh HM; Sesay AB; Caulker AF; Samai M; Thomas V; Farrell N; Widdowson MA
J Infect Dis; 2018 May; 217(suppl_1):S48-S55. PubMed ID: 29788339
[TBL] [Abstract][Full Text] [Related]
11. Utilizing Nurses to Staff an Ebola Vaccine Clinical Trial in Sierra Leone during the Ebola Outbreak.
Edem-Hotah J; McDonald W; Abu PM; Luman ET; Carter RJ; Koker A; Goldstein ST
J Infect Dis; 2018 May; 217(suppl_1):S60-S64. PubMed ID: 29788340
[TBL] [Abstract][Full Text] [Related]
12. Implementing an Ebola Vaccine Study - Sierra Leone.
Widdowson MA; Schrag SJ; Carter RJ; Carr W; Legardy-Williams J; Gibson L; Lisk DR; Jalloh MI; Bash-Taqi DA; Kargbo SA; Idriss A; Deen GF; Russell JB; McDonald W; Albert AP; Basket M; Callis A; Carter VM; Ogunsanya KR; Gee J; Pinner R; Mahon BE; Goldstein ST; Seward JF; Samai M; Schuchat A
MMWR Suppl; 2016 Jul; 65(3):98-106. PubMed ID: 27387395
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial.
Zhu FC; Wurie AH; Hou LH; Liang Q; Li YH; Russell JB; Wu SP; Li JX; Hu YM; Guo Q; Xu WB; Wurie AR; Wang WJ; Zhang Z; Yin WJ; Ghazzawi M; Zhang X; Duan L; Wang JZ; Chen W
Lancet; 2017 Feb; 389(10069):621-628. PubMed ID: 28017399
[TBL] [Abstract][Full Text] [Related]
14. Getting the most from the Ebola vaccine success.
Focosi D; Maggi F; Pistello M
Vaccine; 2015 Dec; 33(51):7141. PubMed ID: 26555349
[No Abstract] [Full Text] [Related]
15. Infectious Diseases. Ebola vaccine trials raise ethical issues.
Cohen J; Kupferschmidt K
Science; 2014 Oct; 346(6207):289-90. PubMed ID: 25324364
[No Abstract] [Full Text] [Related]
16. Perceptions and acceptability of an experimental Ebola vaccine among health care workers, frontline staff, and the general public during the 2014-2015 Ebola outbreak in Sierra Leone.
Jalloh MF; Jalloh MB; Albert A; Wolff B; Callis A; Ramakrishnan A; Cramer E; Sengeh P; Pratt SA; Conteh L; Hajjeh R; Bunnell R; Redd JT; Ekström AM; Nordenstedt H
Vaccine; 2019 Mar; 37(11):1495-1502. PubMed ID: 30755367
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study.
Heppner DG; Kemp TL; Martin BK; Ramsey WJ; Nichols R; Dasen EJ; Link CJ; Das R; Xu ZJ; Sheldon EA; Nowak TA; Monath TP;
Lancet Infect Dis; 2017 Aug; 17(8):854-866. PubMed ID: 28606591
[TBL] [Abstract][Full Text] [Related]
18. The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial.
Huttner A; Dayer JA; Yerly S; Combescure C; Auderset F; Desmeules J; Eickmann M; Finckh A; Goncalves AR; Hooper JW; Kaya G; Krähling V; Kwilas S; Lemaître B; Matthey A; Silvera P; Becker S; Fast PE; Moorthy V; Kieny MP; Kaiser L; Siegrist CA;
Lancet Infect Dis; 2015 Oct; 15(10):1156-1166. PubMed ID: 26248510
[TBL] [Abstract][Full Text] [Related]
19. EBOVAC-Salone: Lessons learned from implementing an Ebola vaccine trial in an Ebola-affected country.
Mooney T; Smout E; Leigh B; Greenwood B; Enria L; Ishola D; Manno D; Samai M; Douoguih M; Watson-Jones D
Clin Trials; 2018 Oct; 15(5):436-443. PubMed ID: 29895178
[TBL] [Abstract][Full Text] [Related]
20. Lessons learned from engaging communities for Ebola vaccine trials in Sierra Leone: reciprocity, relatability, relationships and respect (the four R's).
Dada S; McKay G; Mateus A; Lees S
BMC Public Health; 2019 Dec; 19(1):1665. PubMed ID: 31829223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
